Clinical Role of FDG PET in Evaluation of Cancer Patients
Top Cited Papers
- 1 March 2003
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 23 (2), 315-340
- https://doi.org/10.1148/rg.232025705
Abstract
Positron emission tomography (PET) is a diagnostic imaging technique that allows identification of biochemical and physiologic alterations in tumors. Use of PET performed with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) significantly improves the accuracy of tumor imaging. In terms of oncologic applications, FDG PET has already gained widespread acceptance in the initial staging of cancer, management of recurrent cancer, and monitoring the response to therapy. With conventional imaging modalities, size criteria are used to distinguish between benign and malignant disease in lymph nodes; conversely, FDG PET is based on identification of fundamental aspects of tumor metabolism. FDG uptake in tumors is proportional to the metabolic rate of viable tumor cells, which have an increased demand for glucose. The high sensitivity and high negative predictive value of FDG PET in most malignant tumors enable this technique to play an even greater role in tumor management at initial staging and follow-up.Keywords
This publication has 89 references indexed in Scilit:
- Value of Positron Emission Tomography With [F-18]Fluorodeoxyglucose in Patients With Colorectal Liver Metastases: A Prospective StudyJournal of Clinical Oncology, 2002
- Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancerBritish Journal of Surgery, 1999
- Staging of the Axilla in Breast CancerAnnals of Surgery, 1998
- Positron emission tomography – a useful imaging technique for otolaryngology, head and neck surgery?The Journal of Laryngology & Otology, 1998
- Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistryEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Glucose transporter gene expression: Regulation of transcription and mRNA stabilityPharmacology & Therapeutics, 1995
- Staging non—small cell lung cancer by whole-body positron emission tomographic imagingThe Annals of Thoracic Surgery, 1995
- Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imagingEuropean Journal of Surgical Oncology, 1995
- Preoperative identification of benign versus malignant parotid masses: A comparative study including positron emission tomographyThe Laryngoscope, 1995
- Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patientsJournal of Surgical Oncology, 1993